FDA pick parries questions at collegial confirmation hearing
By RICARDO ALONSO-ZALDIVAR and MATTHEW PERRONE
Associated Press
WASHINGTON (AP) — President Joe Biden’s pick to lead the Food and Drug Administration deftly parried questions on crises ranging from the COVID pandemic to the opioid epidemic. Dr. Robert Califf’s collegial hearing Tuesday before the Senate Health, Education, Labor and Pensions committee seemed to bode well for his confirmation. Califf promised that if confirmed he would use data to streamline the approval of COVID treatments and tests, conduct a full review of the agency’s controversial handling of opioid painkillers, maintain focus on tobacco regulation, work to make prescription drugs more affordable, and confront medical misinformation on social media.
